The AKT pathway is also involved in modulating chemoresistance of human cancer cells (Deng et al., 2019), which, together with the findings on STK35-CRC resistance toward 5-FU, indicates close relationships among STK35, the AKT signaling pathway, and CRC chemoresistance. Here, AKT1 is linked to colorectal carcinoma.